Diabetes mellitus is a severe disease that leads to an early disability and premature death. Diabetic cardiac autonomic neuropathy (DCAN) is a serious and frequent complication of diabetes mellitus with a poor prognosis. Timely diagnosis of DCAN can have important clinical implications, since DCAN is an independent risk factor for cardiovascular mortality, arrhythmias, painless ischemia, and other cardiovascular disorders. Despite this, until now, in clinical practice, they are rarely engaged in an active search for the symptoms of DCAN and it remains a poorly studied and rarely diagnosed complication of diabetes mellitus. The article discusses the methods of detecting and assessing DACN in clinical practice, including the assessment of clinical manifestations, the use of reflex cardiovagal tests and common instrument6al diagnostic methods.
- 1. Строков, И. А. Диабетическая кардиальная автономная невропатия / И. А. Строков, А. В. Зилов, А. А. Фокина, Ж. С. Альбекова, В. А. Головачева // Лечебное дело. – 2013. – № 1. –С. 49–54.
- 2. Vinik, A. I., Erbas T. Diabetic autonomic neuropathy /A. I. Vinik, T. Erbas // Handb Clin Neurol. – 2013. – Vol. 117. –P. 279–94.
- 3. Spallone, V. Update on the Impact, Diagnosis and Management of Cardiovascular Autonomic Neuropathy in Diabetes: What Is Defined, What Is New, and What Is Unmet / V. Spallone // Diabetes Metab J. – 2019. – Vol. 43(1). – P. 3–30. – doi: 10.4093/dmj.2018.0259.
- 4. Desouza, C. V. Hypoglycemia, diabetes, and cardiovascular events / C. V. Desouza, G. B. Bolli, V. Fonseca // Diabetes Care. – 2010. – № 33(6). – Р. 1389–394. – https://doi.org/10.2337/dc09-2082.
- 5. Spallone, V. Toronto Consensus Panel on Diabetic Neuropathy. Cardiovascular autonomic neuropathy in diabetes: clinical impact, assessment, diagnosis, and management / V. Spallone, D. Ziegler, R. Freeman [et al.] // Diabetes Metab. Res. Rev. – 2011. – № 27. – Р. 639–653.
- 6. Edwards, J. L. Diabetic Neuropathy: Mechanisms to Management / J. L. Edwards, A. Vincent, T. Cheng, E. L. Feldman // Pharmacol Ther. – 2008. – Vol. 120(1). – P. 1–34.
- 7. Kahn, R. Proceedings of a consensus development conference on standardized measures in diabetic neuropathy. Autonomic nervous system testing / R. Kahn // Diabetes Care. – 1992. – Т. 15, № 8. – P. 1095–1103.
- 8. Physical activity and autoimmune diseases: Get moving and manage the disease / K. Sharif [et al.] // Autoimmunity Reviews. – 2018. – Vol. 17, № 1. – P. 53–72.
- 9. Heart rate variability: standards of measurement, physiological interpretation and clinical use. Task Force of the Europe an Society of Cardiology and the American Society of Pacing Electrophysiology. Heart rate variability: standards of measurement, physiological interpretation, and clinical use // Circulation. – 1996. – Vol. 93. – P. 1043–1065.
- 10. Lin, K., Wei L., Huang Z., Zeng Q. Combination of Ewing test, heart rate variability, and heart rate turbulence analysis for early diagnosis of diabetic cardiac autonomic neuropathy /K. Lin, L. Wei, Z. Huang, O. Zeng // Medicine (Baltimore). – 2017. – Vol. 96(45). – P. e8296. – doi: 10.1097/MD.0000000000008296.
- 11. Tavakoli, M., Begum P., McLaughlin J., Malik R. A. Corneal confocal microscopy for the diagnosis of diabetic autonomic neuropathy // Muscle Nerve. – 2015. – Vol. 52. – P. 363–70.
- Refernces
- 1. Strokov, I. A. Diabeticheskaja kardial’naja avtonomnaja nevropatija / I. A. Strokov, A. V. Zilov, A. A. Fokina, Zh. S. Al’bekova, V. A. Golovacheva // Lechebnoe delo. – 2013. – № 1. – S. 49–54.
- 2. Vinik, A. I., Erbas T. Diabetic autonomic neuropathy /A. I. Vinik, T. Erbas // Handb Clin Neurol. – 2013. – Vol. 117. –P. 279–94.
- 3. Spallone, V. Update on the Impact, Diagnosis and Management of Cardiovascular Autonomic Neuropathy in Diabetes: What Is Defined, What Is New, and What Is Unmet / V. Spallone // Diabetes Metab J. – 2019. – Vol. 43(1). – P. 3–30. – doi: 10.4093/dmj.2018.0259.
- 4. Desouza, C. V. Hypoglycemia, diabetes, and cardiovascular events / C. V. Desouza, G. B. Bolli, V. Fonseca // Diabetes Care. – 2010. – № 33(6). – Р. 1389–394. https://doi.org/10.2337/dc09-2082.
- 5. Spallone, V. Toronto Consensus Panel on Diabetic Neuropathy. Cardiovascular autonomic neuropathy in diabetes: clinical impact, assessment, diagnosis, and management /V. Spallone, D. Ziegler, R. Freeman et al. // Diabetes Metab. Res. Rev. – 2011. – № 27. – Р. 639–653.
- 6. Edwards, J. L. Diabetic Neuropathy: Mechanisms to Management / J. L. Edwards, A. Vincent, T. Cheng, E. L. Feldman // Pharmacol Ther. – 2008. – Vol. 120(1). – P. 1–34.
- 7. Kahn, R. Proceedings of a consensus development conference on standardized measures in diabetic neuropathy. Autonomic nervous system testing / R. Kahn // Diabetes Care. – 1992. – Т. 15, № 8. – P. 1095–1103.
- 8. Physical activity and autoimmune diseases: Get moving and manage the disease / K. Sharif [et al.] // Autoimmunity Reviews. – 2018. – Vol. 17, № 1. – P. 53–72.
- 9. Heart rate variability: standards of measurement, physiological interpretation and clinical use. Task Force of the European Society of Cardiology and the American Society of Pacing Electrophysiology. Heart rate variability: standards of measurement, physiological interpretation, and clinical use // Circulation. – 1996. – Vol. 93. – P. 1043–1065.
- 10. Lin, K., Wei L., Huang Z., Zeng Q. Combination of Ewing test, heart rate variability, and heart rate turbulence analysis for early diagnosis of diabetic cardiac autonomic neuropathy /K. Lin, L. Wei, Z. Huang, O. Zeng // Medicine (Baltimore). – 2017. – Vol. 96(45). – P. e8296. – doi: 10.1097/MD.0000000000008296.
- 11. Tavakoli, M., Begum P., McLaughlin J., Malik R. A. Corneal confocal microscopy for the diagnosis of diabetic autonomic neuropathy // Muscle Nerve. – 2015. – Vol. 52. – P. 363–70.